ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Virology
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1683277
Brain Virome Dysbiosis in Parkinson's Disease and Multiple System Atrophy
Provisionally accepted- Karolinska Institutet (KI), Solna, Sweden
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Viral elements have been reported in human brain tissue, yet their presence in the putamen— a region critically affected in Parkinson's disease (PD) and Multiple system atrophy (MSA)has not been characterized. We analyzed whole-genome sequencing data from 32 post-mortem putamen samples (PD: n = 10; MSA: n = 10; healthy controls: n = 12) available under NCBI BioProjects PRJNA756274, PRJNA563007, PRJNA321439, PRJNA555211, and PRJNA555099. Using MetaPhlAn4 for virome profiling, LEfSe for biomarker discovery, and Wilcoxon and ROC analyses for validation, we found that neurodegenerative samples exhibited significantly higher virome alpha diversity compared to healthy controls. LEfSe analysis revealed nine viral species enriched in the neurodegenerative group, including Pestivirus A, Pestivirus Giraffe-1, Woolly monkey sarcoma virus, Abelson murine leukemia virus, Murine osteosarcoma virus, Human endogenous retrovirus K, Salmonella virus SP6, Taterapox virus, and Saccharomyces cerevisiae killer virus M1 (LDA score >2; P < 0.05). In contrast, Alcelaphine gammaherpesvirus 1 was more abundant in controls. While the functional roles of these viruses in the brain remain to be established, several have been previously linked to immunomodulatory effects, suggesting possible relevance to neurodegenerative disease processes. This pilot study provides the first evidence of a brain virome in the human putamen and suggests a potential link between virome dysbiosis and neurodegenerative disease. Distinct viral signatures identified in PD and MSA may serve as candidate biomarkers for early detection and diagnosis.
Keywords: Brain virome, Parkinson's disease, Multiple System Atrophy, Brain dysbiosis, Putamen
Received: 10 Aug 2025; Accepted: 29 Sep 2025.
Copyright: © 2025 Ghorbani, Gabarrini and Hajikhezri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mahin Ghorbani, mahin.ghorbani@ki.se
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.